PHS
CLVS

PFM Health Sciences’s Clovis Oncology, Inc. CLVS Stock Holding History

PFM Health Sciences’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-750,200
Closed -$22M – 127
2018
Q3 		$22M Sell
750,200
-34,500
-4% -$1.34M 0.32% 88
2018
Q2 		$35.7M Buy
+784,700
New +$38.2M 0.56% 68
2016
Q2 		– Sell
-804,100
Closed -$15.4M – 107
2016
Q1 		$15.4M Buy
804,100
+479,000
+147% +$10.1M 0.48% 52
2015
Q4 		$11.4M Buy
+325,100
New +$21M 0.35% 54

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

PFM Health Sciences's CLVS Position: Q4 2018 in Review

PFM Health Sciences sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 1,927,928 shares — an estimated $56.6M sold.

PFM Health Sciences first reported a position in CLVS in Q2 2013 and held it in 20 quarters. The position peaked at $238M in Q2 2015. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • PFM Health Sciences reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • PFM Health Sciences sold 1,927,928 Clovis Oncology, Inc. shares in Q4 2018, an estimated $56.6M.
  • PFM Health Sciences first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 20 quarters.
  • PFM Health Sciences's Clovis Oncology, Inc. position peaked at $238M in Q2 2015.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.